Arch Point Investors Recursion Pharmaceuticals, Inc. Transaction History

Arch Point Investors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$6.59 - $15.86 $443,111 - $1.07 Million	-67,240 Reduced 6.03%	1,047,386 $8.01 Million
Q4 2022 Feb 13, 2023	SELL	$7.16 - $12.7 $10,740 - $19,050	-1,500 Reduced 0.13%	1,114,626 $8.59 Million
Q3 2022 Nov 14, 2022	SELL	$7.83 - $13.6 $1.18 Million - $2.06 Million	-151,304 Reduced 11.94%	1,116,126 $11.9 Million
Q1 2022 May 13, 2022	BUY	$6.16 - $18.03 $73,920 - $216,360	12,000 Added 0.96%	1,267,430 $9.08 Million
Q4 2021 Feb 11, 2022	BUY	$16.14 - $21.86 $20.3 Million - $27.4 Million	1,255,430 New	1,255,430 $21.5 Million

286

242M

1.35M

2.32M

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.31B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

Get notified when there are updates to the investment portfolio of Arch Point Investors, based on Form 13F filings with the SEC.

Stay updated on Arch Point Investors with notifications on news.